# Mukka Proteins (NSE: MUKKA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/MUKKA · Pivot · prices to 22 Oct 2026

Mukka Proteins (NSE: MUKKA) closed at ₹25.20 on 22 Oct 2026, down 2.33% on the day. With a market capitalisation of ₹756 Cr, it ranks 1588th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Packaged Foods.

At its last close the stock traded at 14.5× trailing earnings, against a return on equity of 10.4% in FY26. Over the past year the share price has fallen 1.4%. Its 52-week range is ₹18.27 (30 Mar 2026) to ₹33.29 (15 Sep 2026); the last close is 24.3% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹368 Cr (−1.2% year on year) and net profit ₹21 Cr (+50.7%), on a consolidated basis. Promoters held 73.33% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹25.20 |
| Market cap | ₹756 Cr |
| P/E (trailing) | 14.5 |
| ROE | 10.4% (FY26) |
| ROCE | 22.1% (FY26) |
| Debt to equity | 1.54 |
| 52-week high | ₹33.29 (15 Sep 2026) |
| 52-week low | ₹18.27 (30 Mar 2026) |
| 1-year return | −1.4% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹368 Cr | −1.2% | ₹21 Cr | +50.7% | ₹0.69 |
| Q3 FY26 | ₹635 Cr | +114.3% | ₹24 Cr | −7.1% | ₹0.79 |
| Q2 FY26 | ₹245 Cr | +68.9% | ₹7 Cr | +1,027.7% | ₹0.20 |
| Q1 FY26 | ₹171 Cr | +2.4% | ₹2 Cr | −62.6% | ₹0.05 |
| Q4 FY25 | ₹372 Cr | +49.0% | ₹14 Cr | −49.1% | ₹0.45 |
| Q3 FY25 | ₹296 Cr | −41.0% | ₹26 Cr | +154.4% | ₹0.88 |
| Q2 FY25 | ₹145 Cr | −55.3% | ₹1 Cr | −97.6% | ₹0.07 |
| Q1 FY25 | ₹167 Cr | −40.8% | ₹5 Cr | −13.8% | ₹0.14 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,006 Cr | ₹47 Cr |
| FY24 | ₹1,380 Cr | ₹71 Cr |
| FY23 | ₹1,177 Cr | ₹46 Cr |
| FY22 | ₹771 Cr | ₹25 Cr |
| FY21 | ₹604 Cr | ₹7 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 73.33%
- Foreign institutions: 1.73%
- Non-institutions: 24.93%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Bcl Industries](https://app.pivotnow.in/stock/BCLIND) | ₹28.85 | ₹852 Cr | 7.4 | — |
| [Dwarikesh Sugar Industries](https://app.pivotnow.in/stock/DWARKESH) | ₹45.61 | ₹845 Cr | 27.5 | — |
| [Vadilal Enter](https://app.pivotnow.in/stock/VADILENT) | ₹9,540.00 | ₹823 Cr | 78.5 | — |
| [Magadh Sugar & Energy](https://app.pivotnow.in/stock/MAGADSUGAR) | ₹558.55 | ₹787 Cr | 12.4 | — |
| [IFB Agro Industries](https://app.pivotnow.in/stock/IFBAGRO) | ₹827.45 | ₹775 Cr | 13.7 | — |
| [Mawana Sugars](https://app.pivotnow.in/stock/MAWANASUG) | ₹176.00 | ₹688 Cr | 18.6 | — |

## Questions and answers

### What is the share price of Mukka Proteins today?

Mukka Proteins (NSE: MUKKA) last closed at ₹25.20 on 22 Oct 2026. Its 52-week high is ₹33.29 and its 52-week low is ₹18.27.

### What is the market cap of Mukka Proteins?

Mukka Proteins' market capitalisation is ₹756 Cr (₹756 Cr) at the 22 Oct 2026 close, ranking 1588th among the NSE companies Pivot tracks.

### What is the P/E ratio of Mukka Proteins?

Mukka Proteins trades at a trailing P/E of 14.5. The median P/E of the 6 closest FMCG peers by market cap is 18.6.

### What is the ROE and ROCE of Mukka Proteins?

Return on equity was 10.4% in FY26 and return on capital employed was 22.1% in FY26 (consolidated figures).

### Is Mukka Proteins a debt-free company?

No. Mukka Proteins' debt-to-equity ratio was 1.54 in FY26, with total debt of ₹32 Cr.

### What were Mukka Proteins' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Mukka Proteins reported revenue of ₹368 Cr, −1.2% year on year, and net profit of ₹21 Cr, +50.7% year on year.

### How has Mukka Proteins stock performed over the last year?

Mukka Proteins' share price has fallen 1.4% over the past year, +8.2% over three months and −10.9% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Mukka Proteins?

As of 30 Jun 2026: promoters 73.33%, foreign institutions 1.73%, non-institutions 24.93%.

### Who are Mukka Proteins' competitors?

The listed FMCG companies closest to Mukka Proteins by market cap are Bcl Industries, Dwarikesh Sugar Industries, Vadilal Enter, Magadh Sugar & Energy, IFB Agro Industries and Mawana Sugars.

### Is Mukka Proteins a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Mukka Proteins' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MUKKA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.